Kolexia
Cancel Mathilde Oncologie médicale
Cancel Mathilde
Oncologie médicale
Centre hospitalier de Tours
Tours, France
84 Activités
6 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Carcinomes Tumeurs de la prostate Néphrocarcinome Métastase tumorale Sarcomes Tumeurs de l'ovaire Sarcome d'Ewing Tumeurs du rein Tumeurs embryonnaires et germinales

Collaborateurs

Voir plus
Linassier Claude
Linassier Claude
Centre hospitalier de Tours, Tours, France
Narciso Berengere
Narciso Berengere
Centre hospitalier de Tours, Tours, France
Léger Cécilia
Léger Cécilia
Centre hospitalier de Tours, Tours, France
Vegas Helene
Vegas Helene
Centre hospitalier de Tours, Tours, France

Industries

Voir plus
Janssen
13 collaboration(s)
Dernière en 2023
Ipsen
7 collaboration(s)
Dernière en 2023
AstraZeneca
6 collaboration(s)
Dernière en 2022
MSD
4 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
AcSé: Secured Access to Pembrolizumab for Patients With Selected Rare Cancer Types
Essai Clinique (Unicancer)   26 février 2024
Savolitinib vs. Sunitinib in MET-driven PRCC.: A Phase III, Open Label, Randomised, Controlled, Multi-Centre Study To Assess the Efficacy and Safety of Savolitinib Versus Sunitinib in Patients With MET-Driven, Unresectable and Locally Advanced, Or Metastatic Papillary Renal Cell Carcinoma (PRCC)
Essai Clinique (AstraZeneca)   16 janvier 2024
Gastrointestinal metastases in renal cell carcinoma: A retrospective multicenter GETUG (Groupe d'Étude des Tumeurs Uro-Génitales) study.
European journal of cancer (Oxford, England : 1990)   15 janvier 2024
Geriatric factors associated with overall survival in older patients with metastatic colorectal cancer.
Clinics and research in hepatology and gastroenterology   03 janvier 2024
Variable effects of periprostatic adipose tissue on prostate cancer cells: Role of adipose tissue lipid composition and cancer cells related factors.
The Prostate   19 décembre 2023
MiR_CPMRC: Search for Predictive Factors of Resistance to Treatment for Metastatic Castration-resistant Prostate Cancer by Studying the Expression of microRNAs
Essai Clinique (CHU Tours)   28 novembre 2023
REGOBONE: A Randomized Phase II, Placebo-controlled, Multicenter Study Evaluating Efficacy and Safety of Regorafenib in Patients With Metastatic Bone Sarcomas
Essai Clinique (Unicancer)   06 novembre 2023
Regorafenib in patients with advanced Ewing sarcoma: results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre Phase II study.
British journal of cancer   01 novembre 2023
GIG-T: Thromboprophylaxis in Good and Intermediate Prognosis Advanced Germ Cell Tumors
Essai Clinique (Gustave-Roussy)   18 octobre 2023
2364MO Durvalumab (D) +/- tremelimumab (T) in combination with dose-dense MVAC (ddMVAC) as neoadjuvant treatment in patients with muscle-invasive bladder carcinoma (MIBC): Results of NEMIO, a randomized phase I-II trial
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023